Anemia Associated With Chronic Kidney Disease Clinical Trial
Official title:
An Open-label, One-center Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease
This open-labeled, one-center study is designed to evaluate the efficacy and safety of roxadustat in ESA-naïve and ESA-treated pediatric patients with CKD Stages 3, 4, and 5 who are receiving dialysis or not. The study will enroll patients between the ages of 2 to <18 years. Approximately 30 patients will be enrolled.
This study is to evaluate the use of roxadustat for renal anemia in pediatric patients with CKD ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03992066 -
Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Hemodialysis Subjects With Anemia Associated With Chronic Kidney Disease
|
Phase 1 | |
| Withdrawn |
NCT04621331 -
Investigating the Efficacy, Safety and PK of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
|
Phase 3 |